The use of mechanical circulatory support for patients presenting with cardiogenic shock is
rapidly increasing. Currently, there is only limited and conflicting evidence available …

In patients with medically refractory heart failure or cardiogenic shock, both temporary and
durable mechanical circulatory support devices can be used to support cardiac circulation …

Advanced heart failure (AHF) presents a complex landscape with challenges spanning
diagnosis, management, and patient outcomes. In response, the integration of multimodality …

Impella and VA-ECMO are two possible therapeutic courses for the treatment of patients with
cardiogenic shock (CS). The study aims to perform a systematic literature review and meta …

Aims Artificial intelligence (AI) has emerged as a potential useful tool to support clinical
treatment of heart failure, including the setting of mechanical circulatory support (MCS) …

Perioperative Management of Patients Receiving Short-term Mechanical Circulatory Support
with the Transvalvular Heart Pump | Anesthesiology | American Society of Anesthesiologists …

The survival rate of cardiac arrest (CA) can be improved by utilizing percutaneous left
ventricular assist devices (pLVADs) instead of conventional chest compressions. However …

Short-term percutaneous mechanical circulatory support by a micro-axial flow pump is
increasingly used to support the left ventricle in cardiogenic shock. After a correct indication …

The use of temporary mechanical circulatory support (tMCS) devices and in particular the
increasing use of the Impella device family has gained significant interest over the last two …

Objective Cardiogenic shock is a critical emergency for which ventricular support devices
(VSDs), such as the Impella (AbioMed Inc, Danvers, MA), are placed. Many referring …